abstract |
Pharmaceutical compositions and methods for treating or preventing edema using anti-T cell agents, anti-TGF-β1 agents, or anti-angiotensin agents (preferably a combination of at least two such agents) are provided. The pharmaceutical composition can be formulated for systemic or local administration and is preferably administered locally. [Selection figure] None |